fbpx Skip to main content

Asthma disproportionately affects minority populations. Given the similar disparity experienced by minorities diagnosed with COVID-19, questions regarding factors that affect these disparities and the relationship between asthma and COVID-19 have been raised. 

This study, published in The Journal of Allergy and Clinical Immunology: In Practice, sought to answer these questions. Results from an anonymous questionnaire distributed to individuals with asthma showed that minorities had worse asthma control than their white counterparts and were simultaneously more likely to be affected by COVID-19.

Minorities experienced higher unemployment rates, more barriers to obtaining asthma medications, and lived in areas with a higher density of COVID-19 cases. Minorities were also more likely to have lost their health insurance as a result of the COVID-19 pandemic. Critically, minorities with asthma had the same health-seeking behaviors as their white counterparts, which implies a structural—and not cultural—barrier to positive health outcomes.

The researchers also distributed a questionnaire to physicians, which found that 28% of physician respondents faced more obstacles when caring for Black patients versus non-Black patients with asthma. Furthermore, nearly a quarter responded that it was more difficult to care for Black patients with asthma during the COVID-19 pandemic.

This study’s implications highlight the relevance of socioeconomic factors and institutional racism to adverse COVID-19 outcomes in minorities with asthma. When looking to reduce the inequity minorities with asthma face during the COVID-19 pandemic, it is critical to focus on these factors. Beneficial interventions could include funneling resources directly into these marginalized communities and enhancing anti-racism and implicit bias training for physicians [1].


You May Also Like::  Two-Day versus Seven-Day Levofloxacin Course for Acute COPD Exacerbation
[1] Baptist, A. P., Lowe, D., Sarsour, N., Jaffee, H., Eftekhari, S., Carpenter, L. M., & Bansal, P. (2020). Asthma Disparities During the COVID-19 Pandemic: A Survey of Patients and Physicians. The Journal of Allergy and Clinical Immunology: In Practice, 8(10), 3371-3377.e1. https://doi.org/10.1016/j.jaip.2020.09.015



“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More